Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
171 The development of small molecule GLP-1RAs aims to overcome some of the limitations of traditional protein or peptide-based GLP-1RAs, such as the need for injection
Hesitation causes more pain because slow needle entry stimulates more nerve endings
48 weeks ~70 syringes Buy in bulk
GLP-1 RAs mimic the endogenous incretin hormone secreted by intestinal L-cells
134979-01-4, CH2COOH-PEG2-NH2.HCl CAS NO.1662688-20-1, Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH CAS NO.1143516-05-5, 17-amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oic acid CAS NO.871-70-5, Octadecanedioic acid Liraglutide intermediates: CAS NO.204521-63-1, Pal-L-Gljavascript:void(0)-OtBu CAS NO.1491158-62-3, Fmoc-Lys(Pal-Glu-OtBu)-OH CAS NO.294855-91-7, Pal-Gljavascript:void(0)-OH CAS NO.536721-25-2, (S)-5-(tert-butoxy)-5-oxo-4-palmitamidopentanoic acid References: [1]
US$ 20.06
US$ 25.19
US$ 21.19
US$ 22.31
US$ 29.62
